<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01084187</url>
  </required_header>
  <id_info>
    <org_study_id>EDAH2010</org_study_id>
    <nct_id>NCT01084187</nct_id>
  </id_info>
  <brief_title>Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction</brief_title>
  <official_title>Correlation of Flow Mediated Dilation of Brachial Artery and Carotid Intima Media Thickness With Erectile Dysfunction Severity and Clinical Response to PDE 5 Inhibitor in Hypertensive Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Pedro Ernesto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Pedro Ernesto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the correlation of FMD of brachial artery and carotid
      intima media thickness with ED severity and clinical response to vardenafil in hypertensive
      men.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To achieve this objective, a prospective study will be conducted, with hypertensive patients
      ranging from 50 to 70 years, presenting vasculogenic erectile dysfunction for over six months
      and sexually actives. All patients will be assessed for clinical and laboratorial data,
      endothelial dysfunction, endothelium independent vasodilation and carotid intima media
      thickness at the inclusion of the study. They will receive medical orientations from the same
      urologist and will return after four attempts with 20 mg of vardenafil.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical response to vardenafil</measure>
    <time_frame>four weeks</time_frame>
    <description>SEP 2; SEP 3 and IIEF variation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>endothelial dysfunction</measure>
    <time_frame>four weeks</time_frame>
    <description>variation of FMD of brachial artery from baseline</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Erectile Dysfunction</condition>
  <condition>Arterial Hypertension</condition>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>vardenafil on demand</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>four sexual attempts with 20 mg vardenafil during next four weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo of vardenafil during four weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>daily vardenafil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 mg of vardenafil each day during four weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vardenafil</intervention_name>
    <description>vardenafil 20 mg on demand or vardenafil daily or placebo</description>
    <arm_group_label>vardenafil on demand</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_label>daily vardenafil</arm_group_label>
    <other_name>Levitra</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  arterial hypertension and erectile dysfunction of vascular origin for at least 6 month

        Exclusion Criteria:

          -  other condition that cause erectile dysfunction such as depression, hypogonadism,
             surgery, trauma, major cardiovascular event
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mario F Neves, MD, PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario Pedro Ernesto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valter Javaroni, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of Rio de Janeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wille Oigman, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>State University of Rio de Janeiro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitário Pedro Ernesto</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>20551030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2010</study_first_submitted>
  <study_first_submitted_qc>March 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2010</study_first_posted>
  <last_update_submitted>April 15, 2011</last_update_submitted>
  <last_update_submitted_qc>April 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2011</last_update_posted>
  <responsible_party>
    <name_title>Valter Javaroni</name_title>
    <organization>Hospital Universitário Pedro Ernesto</organization>
  </responsible_party>
  <keyword>erectile dysfunction</keyword>
  <keyword>arterial hypertension</keyword>
  <keyword>flow mediated vasodilation</keyword>
  <keyword>endothelial dysfunction</keyword>
  <keyword>carotid intima media thickness</keyword>
  <keyword>vardenafil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vardenafil Dihydrochloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

